Human Longevity

BioAro Inc to Host Inaugural Longevity Innovation Forum in Dubai, UAE

Retrieved on: 
Wednesday, January 24, 2024
Nexus, Entrepreneurship, The Ritz-Carlton Hotel Company, Capital, Research, MD, Health, Hypertension, Life, Knowledge, University, Hormone, Gene, Life expectancy, Genetics, Government, Digital, Neuromuscular disease, Longevity, Human Longevity, Exercise, Ageing

DUBAI, UAE, Jan. 24, 2024 /PRNewswire/ - BioAro Inc , a Canadian biotechnology company specializing in precision health and longevity medicine, is excited to announce its inaugural Longevity Innovation Forum, to be held at the Ritz Carlton Hotel, Dubai International Financial District, in Dubai, UAE on January 28, 2024, from 10:30am to 12pm.

Key Points: 
  • DUBAI, UAE, Jan. 24, 2024 /PRNewswire/ - BioAro Inc , a Canadian biotechnology company specializing in precision health and longevity medicine, is excited to announce its inaugural Longevity Innovation Forum, to be held at the Ritz Carlton Hotel, Dubai International Financial District, in Dubai, UAE on January 28, 2024, from 10:30am to 12pm.
  • The Longevity Innovation Forum aims to bring together thought leaders, experts, and innovators in the field of healthy aging and longevity medicine to discuss the latest advancements, opportunities, and challenges in this rapidly evolving field.
  • Distinguished speakers from diverse backgrounds will join the forum, providing invaluable insights and perspectives on the subject matter.
  • Attendance at the Longevity Innovation Forum is by invitation only, with limited spots available for industry professionals, researchers, investors, and stakeholders interested in the field of longevity medicine.

BioAro Inc to Host Inaugural Longevity Innovation Forum in Dubai, UAE

Retrieved on: 
Wednesday, January 24, 2024
Nexus, Entrepreneurship, The Ritz-Carlton Hotel Company, Capital, Research, MD, Health, Hypertension, Life, Knowledge, University, Hormone, Gene, Life expectancy, Genetics, Government, Digital, Neuromuscular disease, Longevity, Human Longevity, Exercise, Ageing

DUBAI, UAE, Jan. 24, 2024 /PRNewswire/ -- BioAro Inc, a Canadian biotechnology company specializing in precision health and longevity medicine, is excited to announce its inaugural Longevity Innovation Forum, to be held at the Ritz Carlton Hotel, Dubai International Financial District, in Dubai, UAE on January 28, 2024, from 10:30am to 12pm.

Key Points: 
  • DUBAI, UAE, Jan. 24, 2024 /PRNewswire/ -- BioAro Inc , a Canadian biotechnology company specializing in precision health and longevity medicine, is excited to announce its inaugural Longevity Innovation Forum, to be held at the Ritz Carlton Hotel, Dubai International Financial District, in Dubai, UAE on January 28, 2024, from 10:30am to 12pm.
  • The Longevity Innovation Forum aims to bring together thought leaders, experts, and innovators in the field of healthy aging and longevity medicine to discuss the latest advancements, opportunities, and challenges in this rapidly evolving field.
  • Distinguished speakers from diverse backgrounds will join the forum, providing invaluable insights and perspectives on the subject matter.
  • Attendance at the Longevity Innovation Forum is by invitation only, with limited spots available for industry professionals, researchers, investors, and stakeholders interested in the field of longevity medicine.

Unlocking the Fountain of Longevity: Longevity Investors Lunch Returns to Davos During WEF, Where Innovation Meets Investment in the Pursuit of Timeless Opportunities

Retrieved on: 
Friday, December 8, 2023
Entrepreneurship, Human Longevity, Conference, Science, Motivation, WEF, Research, Ageless, Health, Education, Insilico Medicine, AI, CPO, MPH, Maximón, Rejuvenation

Zug, Switzerland--(Newsfile Corp. - December 8, 2023) - Longevity Investors Lunch returns for the third edition during the 2024 World Economic Forum (WEF).

Key Points: 
  • Zug, Switzerland--(Newsfile Corp. - December 8, 2023) - Longevity Investors Lunch returns for the third edition during the 2024 World Economic Forum (WEF).
  • The Longevity Investors Conference is the most exclusive conference for longevity investors.
  • "The motivation to organize the Longevity Investors Conference," said Dr. Tobias Reichmuth, Founding Partner and organizer, "is clear: The longevity industry is highly attractive for investors.
  • The Longevity Investors Conference is the most exclusive conference for longevity investors.

Flexjet Updates Partnership Guide With 40+ Iconic Brands From Across the Globe

Retrieved on: 
Wednesday, July 12, 2023
Enterprise, Kaenon Polarized, Travel, Ascot Racecourse, Wine, Atmosphere, TEFAF, OH, Health, Human Longevity, Longevity, Concours, Alternative medicine, Boutique, Alauda, Beretta, Premium Brands Holdings Corporation, Master & Dynamic, Jewellery, Transport, Monterey Car Week, Hotel, Porthos, Flexjet, Quail

Details of the new partners, available only to Flexjet aircraft Owners, are available through a new guide .

Key Points: 
  • Details of the new partners, available only to Flexjet aircraft Owners, are available through a new guide .
  • In addition to convenience advantages, each hotel offers unique benefits available only to Flexjet Owners.
  • Elite Events: One of the most highly requested benefits of Flexjet aircraft ownership is access to elite events.
  • Flexjet aircraft Owners can access more information about the partnerships online through https://www.flexjet.com/partnerships or by contacting their Flexjet concierge.

Nutcracker Therapeutics appoints Cynthia Collins, biopharma veteran and former Editas Medicine CEO, to board of directors

Retrieved on: 
Tuesday, May 9, 2023
Health, Genetics, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, CRISPR, Panavally, University, GE HealthCare, Draper Laboratory, Collins, Human Longevity, Clinical trial, Business, Longevity, ARCH Venture Partners, RNA, David G. Booth, University of Illinois Urbana-Champaign, Editas Medicine, Global Oncology, Baxter International, Therapy, Beckman Coulter, CERT, Pharmaceutical industry, Science, Microbiology, Nutcracker

Nutcracker Therapeutics, Inc. , a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the appointment of Cynthia Collins to the company’s board of directors.

Key Points: 
  • Nutcracker Therapeutics, Inc. , a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the appointment of Cynthia Collins to the company’s board of directors.
  • Collins joins Nutcracker Therapeutics with more than four decades of experience working in the pharmaceutical and biotech industry.
  • Additionally, she is a board member of Poseida Therapeutics (PSTX), Certara (CERT), DermTech (DMTK), Draper Laboratories and Triumvira Immunologics.
  • “We are delighted to welcome Cindy to the board,” says Igor Khandros, Ph.D., CEO of Nutcracker Therapeutics.

Curve Biosciences Appoints Industry Veterans to Leadership Team, Announces Commercial Advisory Board

Retrieved on: 
Wednesday, May 3, 2023
Health, Technology, Other Health, Software, General Health, Research, Science, Acumen, Insurance, Communication, CDTA, Aetna, Marketing, Stanford University, Longevity, Doctor of Philosophy, GRAIL, Genetics, MD, Patient, Conditional sentence, Commercial Operating System, San Francisco, Tissue, University, CSO, Inflammatory bowel disease, Burns, DaVita Inc., Medicine, Chronic condition, Biology, Liver, Cancer, Electrical engineering, Data mining, Biomarker, CVS Health, Chronic liver disease, UnitedHealth Group, Electricity, Endometriosis, University of California, San Francisco, Human Longevity, Genomics, Trial of the century, Biological engineering, World Health Organization, Management, Medical imaging, Pharmaceutical industry, Myriad Genetics, Natera, Curve

“Chuba and Nathan have created, launched, and scaled multiple products, including in early disease detection,” said Ritish Patnaik, PhD , CEO of Curve.

Key Points: 
  • “Chuba and Nathan have created, launched, and scaled multiple products, including in early disease detection,” said Ritish Patnaik, PhD , CEO of Curve.
  • She previously was vice president of Commercial Operations at Counsyl, and held leadership roles at DaVita and MyHealthTeam.
  • He previously held the same role at Serimmune, Inc., and held commercial leadership roles at Human Longevity, Counsyl, AltheaDx and Verinata.
  • We look forward to working with our advisors to maintain our progress and explore commercial opportunities in other chronic diseases.”

Fountain Life Promotes Helen Messier, M.D., Ph.D. to Chief Medical Officer

Retrieved on: 
Tuesday, April 18, 2023
Chief scientific officer, La Jolla Institute for Immunology, University, Doctor of Philosophy, Human Longevity, Genomics, Cancer, Quality of life, Longevity, Medicine, CMO, Medical director, Patient, Honor, Knowledge, Diagnosis, Immunology, AI, Health, Family, Conditional sentence, Disease, Medical device, Nursing, Genetics

NAPLES, Fla., April 18, 2023 /PRNewswire/ -- Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the promotion of Helen Messier, M.D., Ph.D. to Chief Medical Officer (CMO). Dr. Messier joined Fountain Life in 2022 as Chief Clinical and Scientific Officer. She is a scientist and a certified family practice physician who has devoted most of her career to harnessing data to close the translational gap in medicine. She has cultivated a unique capability of integrating multi-omics data and digital health technologies into real-world clinical care to enable patients to realize the beneficial potential of biomedical technologies. 

Key Points: 
  • Dr. Messier joined Fountain Life in 2022 as Chief Clinical and Scientific Officer.
  • "Helen's background as a practicing physician, combined with her expertise in clinical science and digital health, make her an exceptional choice for the chief medical officer role at Fountain Life," said Bill Kapp, M.D., Fountain Life CEO and co-founder.
  • In her role as CMO, Dr. Messier will lead the company's medical, clinical, and scientific teams and oversee the establishment of Fountain Life University.
  • Fountain Life University is designed to train Fountain Life certified practitioners.

ROTH MKM to Host 35th Annual Roth Conference from March 12-14 in Dana Point, California

Retrieved on: 
Monday, March 6, 2023
Carbon, Yoga, Conference, LNG, Natural gas, Agtech, Natural Resources, Partnership, New Frontier, Athlete, Partner, Sport, Wellness, Acquisition, SPAC, PINK, Metal, The Ritz-Carlton Hotel Company, Tennis, Love, Challenge, Human Longevity, ESG, CAF, Athletic, Longevity, Digital branding, MKM, Ageing, Sense, Consumer, The Ritz-Carlton Millenia Singapore, Human, New Public Management, Loeb, Hotel, Management, Health care, Mining

NEWPORT BEACH, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- ROTH MKM (“Roth”), www.roth.com , will host its 35th Annual Conference on March 12-14, 2023, at The Ritz Carlton, Laguna Niguel, located in Dana Point, CA.

Key Points: 
  • NEWPORT BEACH, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- ROTH MKM (“Roth”), www.roth.com , will host its 35th Annual Conference on March 12-14, 2023, at The Ritz Carlton, Laguna Niguel, located in Dana Point, CA.
  • The annual Roth Conference offers companies an extraordinary platform for relationship building with both existing and prospective institutional investors.
  • Following its recent acquisition of MKM Partners, ROTH MKM looks forward to introducing the conference setting to many new employees and their clients.
  • In partnership with the 35th Annual Roth Conference, Socialsuite has prepared a short survey on ESG.

Experity Announces Appointment of Brian Berning as Chief Financial Officer

Retrieved on: 
Wednesday, January 4, 2023
Software, Practice Management, General Health, Health, Hospitals, Health Technology, Technology, Health Insurance, Business administration, IPO, Corporate development, Ernst, Associate, LPL Financial, Ernst & Young, CFO, Multimedia, GTCR, San Diego State University, Genomics, CPA, Longevity, Acquisition, Growth, Patient, University, Health care, SVP, Berne Union, Human Longevity, Management, Laminacauda expers

Experity , the national leader in on-demand healthcare solutions, announced the appointment of Brian Berning as the company’s new Chief Financial Officer.

Key Points: 
  • Experity , the national leader in on-demand healthcare solutions, announced the appointment of Brian Berning as the company’s new Chief Financial Officer.
  • This appointment follows the recent acquisition of Experity by GTCR, a leading private equity firm.
  • View the full release here: https://www.businesswire.com/news/home/20230104005089/en/
    Brian Berning, Chief Financial Officer of Experity (Photo: Business Wire)
    Berning first joined Experity from Corza Health in July of 2022 as Chief Corporate Development Officer to lead the company’s merger and acquisition efforts.
  • As CFO, Berning will continue the company’s M&A initiatives, lead financial planning processes, and act as the financial liaison between Experity’s creditors and board of directors.

Fountain Life Appoints Helen Messier, M.D., Ph.D., as Chief Clinical and Scientific Officer

Retrieved on: 
Wednesday, December 7, 2022
Chief scientific officer, Immunology, Physician, Longevity, Education, Life, Diagnosis, Neurodegeneration, Patient, Cancer, Family, Genomics, University, Medicine, Bohemia Interactive, Quality of life, Artificial intelligence, Human Longevity, Doctor of Philosophy, Health, Medical director, La Jolla Institute for Immunology, Honor, Medical device, Genetics

NAPLES, Fla., Dec. 6, 2022 /PRNewswire/ -- Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Helen Messier, M.D., Ph.D., as the company's first Chief Clinical and Scientific Officer. Dr. Messier is a scientist and a certified family practice physician who has devoted most of her career to harnessing data to close the translational gap in medicine. She has cultivated a unique capability of integrating multi-omics data and digital health technologies in real-world clinical care to enable patients to realize the beneficial potential of biomedical technologies.

Key Points: 
  • "Helen brings a unique medical and scientific background to Fountain Life, and we are excited to add her insights and expertise to our leadership team," said Bill Kapp, M.D., Fountain Life CEO and co-founder.
  • In addition to leading the company's clinical and scientific programs, Dr. Messier will establish Fountain Life University to train Fountain Life certified practitioners and lead the effort to gain insights and publish findings from Fountain Life's vast amount of data.
  • Bringing the capabilities of Fountain Life to more people is key to positively affecting patient outcomes that lead to improved quality of life."
  • Fountain Life brings together the world's most renowned scientists and physicians to boost longevity and performance putting health back in healthcare.